Elevated AURKB expression is associated with adverse cytogenetic abnormalities and high white blood cell counts in patients with AML.[38] Additionally, AURKB inhibition has been shown to effectively inhibit AML‐related cell proliferation.[39] These studies provide substantial evidence for the pivotal role of AURKB in AML progression. This evidence concerns the gene AURKB and acute myeloid leukemia.